ANIP
ANI Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$71.33
−0.92%Forward multiples
Based on analyst estimates
- P/E forward
- 7.58x
- P/E 2026E
- 7.69x
- P/E 2027E
- 6.84x
- P/E 2028E
- 5.98x
- P/S forward
- 1.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.77x
- PEG TTM
- 0.16x
- Price / book
- 2.74x
- Price / sales
- 1.67x
- Price / cash flow
- 8.64x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 1.63x
- EV / EBITDA
- 6.22x
- EV / EBIT
- 10.60x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026